Research ArticleVascular Biology

Leukotriene B4 antagonism ameliorates experimental lymphedema

See allHide authors and affiliations

Science Translational Medicine  10 May 2017:
Vol. 9, Issue 389, eaal3920
DOI: 10.1126/scitranslmed.aal3920

Article Information

vol. 9 no. 389

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication November 11, 2016
  • Resubmitted November 22, 2016
  • Accepted for publication April 4, 2017

Author Information

  1. Wen Tian1,2,*,
  2. Stanley G. Rockson2,*,,
  3. Xinguo Jiang1,2,*,
  4. Jeanna Kim2,*,
  5. Adrian Begaye2,
  6. Eric M. Shuffle1,2,
  7. Allen B. Tu1,2,
  8. Matthew Cribb3,
  9. Zhanna Nepiyushchikh3,
  10. Abdullah H. Feroze2,
  11. Roham T. Zamanian2,
  12. Gundeep S. Dhillon2,
  13. Norbert F. Voelkel4,
  14. Marc Peters-Golden5,
  15. Jan Kitajewski6,
  16. J. Brandon Dixon3 and
  17. Mark R. Nicolls1,2,*,
  1. 1VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.
  2. 2Stanford University School of Medicine, Stanford, CA 94305, USA.
  3. 3Georgia Institute of Technology, Atlanta, GA 30332, USA.
  4. 4Virginia Commonwealth University, Richmond, VA 23284, USA.
  5. 5University of Michigan Health Systems, Ann Arbor, MI 48109, USA.
  6. 6University of Illinois at Chicago, Chicago, IL 60612, USA.
  1. Corresponding author. Email: rockson{at}stanford.edu (S.G.R.); mnicolls{at}stanford.edu (M.R.N.)
    • * These authors contributed equally to this work.

    AltMetrics

    Article usage

    AbstractFullPDF
    May 20177929253506
    Jun 2017391064101
    Jul 201741273745
    Aug 201743754645
    Sep 201719313345